Lynn Seely
2019
In 2019, Lynn Seely earned a total compensation of $6.2M as Principal Executive Officer at Myovant Sciences Ltd., a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $433,000 |
|---|---|
| Option Awards | $5,188,188 |
| Salary | $601,000 |
| Other | $479 |
| Total | $6,222,667 |
Seely received $5.2M in option awards, accounting for 83% of the total pay in 2019.
Seely also received $433K in non-equity incentive plan, $601K in salary and $479 in other compensation.
Rankings
In 2019, Lynn Seely's compensation ranked 1,615th out of 13,971 executives tracked by ExecPay. In other words, Seely earned more than 88.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,615 out of 13,971 | 88th |
Division Manufacturing | 579 out of 5,692 | 90th |
Major group Chemicals And Allied Products | 174 out of 2,189 | 92nd |
Industry group Drugs | 140 out of 1,875 | 93rd |
Industry Pharmaceutical Preparations | 105 out of 1,387 | 92nd |
Source: SEC filing on July 24, 2020.
Seely's colleagues
We found two more compensation records of executives who worked with Lynn Seely at Myovant Sciences Ltd. in 2019.